» Articles » PMID: 22261717

Nuclear IGF1R is a Transcriptional Co-activator of LEF1/TCF

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2012 Jan 21
PMID 22261717
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Recent findings suggest that nuclear IGF1R binds to enhancer regions and functions as a transcriptional cofactor. However, the downstream transcriptional regulators of this pathway remain to be defined. Here, we show that nuclear IGF1R associates with the transcription factor LEF1 and increases promoter activity of LEF1 downstream target genes cyclin D1 and axin2. Furthermore, nuclear IGF1R augments protein levels of cyclin D1 and axin2. Our findings suggest a novel function for IGF1R, thus further emphasizing the important role of this receptor in cancer biology.

Citing Articles

The signaling landscape of insulin-like growth factor 1.

Khan M, Zugaza J, Torres Aleman I J Biol Chem. 2024; 301(1):108047.

PMID: 39638246 PMC: 11748690. DOI: 10.1016/j.jbc.2024.108047.


Rewiring of IGF1 secretion and enhanced IGF1R signaling induced by co-chaperone carboxyl-terminus of Hsp70 interacting protein in adipose-derived stem cells provide augmented cardioprotection in aging-hypertensive rats.

Barik P, Kuo W, Kuo C, Hsieh D, Day C, Daddam J Aging (Albany NY). 2023; 15(23):14019-14038.

PMID: 38085649 PMC: 10756089. DOI: 10.18632/aging.205287.


Immunohistochemical Expression of Insulin-Like Growth Factor-1 Receptor and Its Association with Clinicopathological Parameters in Hepatocellular Carcinoma.

Peloso Maia M, Albuquerque R, do Carmo Silva S, Lima C, Diniz P, Vidigal P Oncology. 2023; 102(6):494-502.

PMID: 37989120 PMC: 11152013. DOI: 10.1159/000535332.


IGF-1R targeting in cancer - does sub-cellular localization matter?.

Soni U, Jenny L, Hegde R J Exp Clin Cancer Res. 2023; 42(1):273.

PMID: 37858153 PMC: 10588251. DOI: 10.1186/s13046-023-02850-7.


The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities.

Werner H Int J Mol Sci. 2023; 24(19).

PMID: 37834331 PMC: 10573540. DOI: 10.3390/ijms241914882.


References
1.
Sasaoka T, Rose D, Jhun B, Saltiel A, Draznin B, Olefsky J . Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem. 1994; 269(18):13689-94. View

2.
Bruhn L, Munnerlyn A, Grosschedl R . ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev. 1997; 11(5):640-53. DOI: 10.1101/gad.11.5.640. View

3.
Levanon D, Goldstein R, Bernstein Y, Tang H, Goldenberg D, Stifani S . Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A. 1998; 95(20):11590-5. PMC: 21685. DOI: 10.1073/pnas.95.20.11590. View

4.
Guvakova M, Surmacz E . Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res. 1997; 231(1):149-62. DOI: 10.1006/excr.1996.3457. View

5.
Wu A, Chen J, Baserga R . Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes. Oncogene. 2007; 27(3):397-403. DOI: 10.1038/sj.onc.1210636. View